Amanda Hays

643 total citations
17 papers, 306 citations indexed

About

Amanda Hays is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Amanda Hays has authored 17 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Amanda Hays's work include Virus-based gene therapy research (3 papers), Single-cell and spatial transcriptomics (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Amanda Hays is often cited by papers focused on Virus-based gene therapy research (3 papers), Single-cell and spatial transcriptomics (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Amanda Hays collaborates with scholars based in United States, Canada and Germany. Amanda Hays's co-authors include Bruno Hagenbuch, Udayan Apte, Susan W. Denfield, Colin J. McMahon, Jack F. Price, Benjamin W. Eidem, Sherif F. Nagueh, Ricardo H. Pignatelli, Jeffrey A. Towbin and Sarah K. Clunie and has published in prestigious journals such as Circulation, Biochemistry and International Journal of Molecular Sciences.

In The Last Decade

Amanda Hays

16 papers receiving 297 citations

Peers

Countries citing papers authored by Amanda Hays

Since Specialization

Citations

This map shows the geographic impact of Amanda Hays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Hays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Hays more than expected).

Fields of papers citing papers by Amanda Hays

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Hays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Hays. The network helps show where Amanda Hays may publish in the future.

Co-authorship network of co-authors of Amanda Hays

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Hays. A scholar is included among the top collaborators of Amanda Hays based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Hays. Amanda Hays is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines 2024 ·Cytometry Part B Clinical Cytometry ·Sara A. Monaghan, Steven Eck, Silvia T. Bunting, (unknown), Robert J. Durso, (unknown), Amanda Hays, Andrea Illingworth, (unknown), (unknown), Megan McCausland, Thomas W. McCloskey, (unknown), Min Shi, Paul K. Wallace, Virginia Litwin, Wolfgang Kern, George Deeb, (unknown), Horatiu Olteanu	3
2	Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum 2024 ·Bioanalysis ·William T. Williams, Kathryn J. Lindley, Hong Liao, Lynn Kamen, Michelle S. Miller, Amanda Hays, Jeffrey Sailstad	2
3	Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain 2024 ·Cytometry Part B Clinical Cytometry ·(unknown), Wolfgang Kern, Małgorzata Kajstura, Eda K. Holl, Amanda Hays, Benjamin D. Hedley, (unknown), Evan R. Jellison, Thomas W. McCloskey, (unknown), Jennifer Rebeles, Madhu M. Ouseph	1
4	Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays 2023 ·Pharmaceutical Research ·(unknown), (unknown), (unknown), (unknown), Michelle S. Miller, Lynn Kamen, (unknown), Roman Wernyj, Richie Khanna, Jim McNally, Amanda Hays	4
5	Utilization of a technology-assisted workflow to prepare controlled substance oral syringes 2023 ·American Journal of Health-System Pharmacy ·(unknown), (unknown), Jamie M. Anderson, Amanda Hays, (unknown), (unknown)	3
6	Bioanalytical Assay Strategies and Considerations for Measuring Cellular Kinetics 2022 ·International Journal of Molecular Sciences ·Amanda Hays, Jennifer N. Durham, (unknown), Nathan P. Rudemiller, Thomas Schneider	6
7	Best Practices in qPCR and dPCR Validation in Regulated Bioanalytical Laboratories 2022 ·The AAPS Journal ·Amanda Hays, Rafiq Islam, Katie Matys, (unknown)	21
8	Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays? 2022 ·The AAPS Journal ·Amanda Hays, Lakshmi Amaravadi, Carmen Fernández‐Metzler, Lindsay King, Joel Mathews, Ni Yan, (unknown), (unknown), Faye Vazvaei, Jianing Zeng	1
9	ASHP Guidelines on Preventing Diversion of Controlled Substances 2022 ·American Journal of Health-System Pharmacy ·John Spencer Clark, Toni Fera, (unknown), (unknown), Amanda Hays, (unknown), (unknown), (unknown), (unknown), (unknown)	12
10	AAPS Perspective on the EURL Recommendation on the use of Non-Animal-Derived Antibodies 2021 ·The AAPS Journal ·Boris Gorovits, Amanda Hays, (unknown), Ceri Jones, (unknown), (unknown), Johanna Mora, Michael A. Partridge, (unknown), (unknown), (unknown), Hao Shen, Gary C. Starling	4
11	Deploying a Rapid Point-Of-Care Polymerase Chain Reaction Test for Sars-Cov-2 in a Clinical Research Unit to Ensure Healthy Volunteer Safety 2021 ·Bioanalysis ·(unknown), (unknown), (unknown), Amanda Hays, (unknown)	1
12	Extending Flow Cytometry Sample Stability by Freezing Lysed Whole Blood for Clinical Monitoring of Treg 2020 ·Bioanalysis ·Jing Yu, Susmita Jasti, (unknown), Amanda Hays	0
13	Cysteine Scanning Mutagenesis of Transmembrane Domain 10 in Organic Anion Transporting Polypeptide 1B1 2014 ·Biochemistry ·(unknown), Amanda Hays, Bruno Hagenbuch	15
14	Organic Anion Transporting Polypeptides Expressed in Pancreatic Cancer May Serve As Potential Diagnostic Markers and Therapeutic Targets for Early Stage Adenocarcinomas 2013 ·Pharmaceutical Research ·Amanda Hays, Udayan Apte, Bruno Hagenbuch	45
15	Transport by OATP1B1 and OATP1B3 Enhances the Cytotoxicity of Epigallocatechin 3-O-Gallate and Several Quercetin Derivatives 2013 ·Journal of Natural Products ·Yuchen Zhang, Amanda Hays, (unknown), (unknown), Duy H. Hua, Bruno Hagenbuch	32
16	Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy 2004 ·Circulation ·Colin J. McMahon, Sherif F. Nagueh, Ricardo H. Pignatelli, Susan W. Denfield, William J. Dreyer, Jack F. Price, Sarah K. Clunie, Louis I. Bezold, Amanda Hays, Jeffrey A. Towbin, Benjamin W. Eidem	149
17	Peripheral Nerve Immunohistochemistry in Diabetic Neuropathy 1996 ·Seminars in Neurology ·David S. Younger, Gorazd Rosoklija, Amanda Hays	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact